Objectives: A longitudinal study was designed to quantify tumor tissue content of vascular endothelial growth factor ( VEGF) in patients with colorectal cancer (CRC) and to evaluate its prognostic value in respect to the relapse-free and overall survivals. Methods: Sixty-nine patients with CRC were followed from the time of diagnosis of primary tumor for at least 3 years after surgery. Quantitative evaluation of VEGF content in tissue was performed on whole protein extracts obtained from biopsies of histologically confirmed neoplastic tissues and corresponding mucosa, histologically confirmed as 'normal'. Results: VEGF levels were higher in CRC tissues, median 141 pg/mg of protein (interquartile range 70 375), compared with corresponding normal mucosa, median 45 pg/mg of protein ( interquartile range 22 - 78; p < 0.0001), and were associated with the stage of disease ( p = 0.035) by multivariate analysis. Tumor VEGF content was higher in relapsing patients compared with those who remained disease free ( p < 0.001) and was independently associated with relapse-free survival ( p = 0.044). Cox's proportional hazard survival analysis demonstrated that VEGF ( p = 0.035) had an independent prognostic value in respect to overall survival. Conclusions: Elevated tumor VEGF content may discriminate between early and late stages of CRC and may be used as an independent prognostic parameter in the management of these patients. Copyright (C) 2005 S. Karger AG, Basel.

Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer

Ferroni P;Guadagni F;
2005-01-01

Abstract

Objectives: A longitudinal study was designed to quantify tumor tissue content of vascular endothelial growth factor ( VEGF) in patients with colorectal cancer (CRC) and to evaluate its prognostic value in respect to the relapse-free and overall survivals. Methods: Sixty-nine patients with CRC were followed from the time of diagnosis of primary tumor for at least 3 years after surgery. Quantitative evaluation of VEGF content in tissue was performed on whole protein extracts obtained from biopsies of histologically confirmed neoplastic tissues and corresponding mucosa, histologically confirmed as 'normal'. Results: VEGF levels were higher in CRC tissues, median 141 pg/mg of protein (interquartile range 70 375), compared with corresponding normal mucosa, median 45 pg/mg of protein ( interquartile range 22 - 78; p < 0.0001), and were associated with the stage of disease ( p = 0.035) by multivariate analysis. Tumor VEGF content was higher in relapsing patients compared with those who remained disease free ( p < 0.001) and was independently associated with relapse-free survival ( p = 0.044). Cox's proportional hazard survival analysis demonstrated that VEGF ( p = 0.035) had an independent prognostic value in respect to overall survival. Conclusions: Elevated tumor VEGF content may discriminate between early and late stages of CRC and may be used as an independent prognostic parameter in the management of these patients. Copyright (C) 2005 S. Karger AG, Basel.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12078/1757
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 34
social impact